my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Todd Magazine, President, Pfizer Consumer Healthcare, North America announced the appointment of Faissal Tahiri to General Manager, Pfizer Consumer Healthcare, Canada, based in Mississauga, Ontario. Tahiri replaces Suneet Varma, who has taken a position as Regional President, Asia-Pacific, for Pfize more
Ablynx announced that the research collaboration which forms part of its license agreement for Nanobodies to tumour necrosis factor alpha (TNF-alpha) with Pfizer has been extended for another year. Ablynx announced the exclusive research collaboration and license agreement with Pfizer (originally more
Ablynx announced that it has reached a second milestone under the terms of its collaboration with Wyeth Pharmaceuticals, a division of Wyeth. A milestone payment of $4 million has been triggered by the initiation by Wyeth of a first Phase II multiple dose study in patients with rheumatoid arthritis more
Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review Summary Immtech Pharmaceuticals, Inc. (Immtech) is a pharmaceutical company that focuses on the global opportunities in the healthcare sector. It is engaged in the discovery and development of therapies for the tre more
GBI Research's "Specialty Pharmaceutical Industry - 2011 Yearbook” essentially provides insights on specialty pharmaceutical sales and price forecasts until 2017. The report provides in-depth therapeutics analysis of eight niche indications, namely: Human Immunodeficiency Virus (HIV)/Acquired immune more
Biotie Therapies Corp. (Biotie) is a biotechnology company, engaged in the discovery and development of therapeutics for the treatment of central nervous system and inflammatory diseases. The company's develops pipeline products which includes, Nalmefene is an opioid receptor antagonist for alcohol more
Contact | FAQ | Site Map About – Vision – Management – The Board – Pharmaceutical Partners – Investors – Business Strategy – Corporate Governance – Company FAQ – Contact LNA Drug Platform – Drug Discovery Engine – microRNA – mRNA – Publications Product Pipeline – Drug Candidates Intellectual Pro more
Skip to the content Circassia Holdings Ltd Controlling the Immune System Home People Portfolio Partners News Contact People Circassia boasts a management team of experienced managers with an outstanding track record in the industry. The team combines strong development experience with proven commerc more
FAQs Brochure Home Latest News! NiKem Research Receives Authorization for Rodent Toxicology Studies (May 3rd, 2010) NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chr more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
